Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population

被引:32
作者
Bygdell, Maria [1 ]
Brunlof, Gertrud [1 ]
Wallerstedt, Susanna M. [1 ]
Kindblom, Jenny M. [1 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
adverse drug reactions; psychiatric; children; pediatric; off-label; SWEDIS; OFF-LABEL; SUICIDAL IDEATION; CHILDREN; MEDICINES; METAANALYSIS; INFORMATION; OUTPATIENTS; DISORDERS; COHORT; USAGE;
D O I
10.1002/pds.2265
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Psychiatric Adverse Drug Reactions (ADRs) are frequent in the pediatric population. The aim of the present study was to analyze spontaneously reported psychiatric ADRs in children during a 10-year period. Methods All spontaneously reported Individual Case Safety Reports (ICSRs) concerning children (< 18 years old) and psychiatric adverse reactions assessed as at least possible, registered in the Swedish Drug Information System (SWEDIS) during the period 2001-2010, were extracted and characterized. Age and sex distribution and labeling/registration status were studied. Results A total of 600 ICSRs concerning 744 psychiatric adverse reactions were identified and included in the analysis. Boys were overrepresented among included ICSRs (60.3% vs. 39.7%; p < .001). After exclusion of vaccines, the three most frequently suspected drugs were montelukast, centrally working sympathomimetic drugs, and inhaled glucocorticoids. Serious adverse reactions were reported more frequently for drugs used off-label than for drugs used according to the Swedish Physician's Desk Reference. Aggressiveness was reported more frequently for boys than for girls as were suicidal conditions. Conclusions Psychiatric ADRs in the pediatric population have been reported for a wide range of reactions and drugs and display age and sex differences including a higher number of suicidal reactions in boys. An association was seen between serious reactions and off-label drug use. Further studies are needed to elucidate safety aspects of unlicensed drugs and drugs used off-label and whether there are differences in children's susceptibility to develop ADRs. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 45 条
[1]   Information about adverse drug reactions reported in children: a qualitative review of empirical studies [J].
Aagaard, Lise ;
Christensen, Arne ;
Hansen, Ebba Holme .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (04) :481-491
[2]   Adverse drug reactions from psychotropic medicines in the paediatric population: Analysis of reports to the Danish Medicines Agency over a decade [J].
Aagaard L. ;
Hansen E.H. .
BMC Research Notes, 3 (1)
[3]   Adverse Drug Reactions in the Paediatric Population in Denmark A Retrospective Analysis of Reports Made to the Danish Medicines Agency from 1998 to 2007 [J].
Aagaard, Lise ;
Weber, Camilla Blicher ;
Hansen, Ebba Holme .
DRUG SAFETY, 2010, 33 (04) :327-339
[4]   Under-reporting of serious adverse drug reactions in Sweden [J].
Bäckström, M ;
Mjörndal, T ;
Dahlqvist, R .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) :483-487
[5]   Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment - A meta-analysis of randomized controlled trials [J].
Bridge, Jeffrey A. ;
Iyengar, Satish ;
Salary, Cheryl B. ;
Barbe, Remy P. ;
Birmaher, Boris ;
Pincus, Harold Alan ;
Ren, Lulu ;
Brent, David A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (15) :1683-1696
[6]   Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years [J].
Busen, NH ;
Britt, RB ;
Rianon, N .
JOURNAL OF ADOLESCENT HEALTH, 2003, 32 (04) :257-259
[7]  
CAPALDI VF, 2010, GHP, V32
[8]  
Carleton BC, 2007, J POPUL THER CLIN PH, V14, pE45
[9]   Unlicensed and off-label drug use in children - Implications for safety [J].
Choonara, I ;
Conroy, S .
DRUG SAFETY, 2002, 25 (01) :1-5
[10]   The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions [J].
Clark, Richard C. ;
Maxwell, Simon R. J. ;
Kerr, Sheena ;
Cuthbert, Melinda ;
Buchanan, Duncan ;
Steinke, Doug ;
Webb, David J. ;
Bateman, Nicholas D. .
DRUG SAFETY, 2007, 30 (04) :357-366